Should You Buy This Biotech Stock Near Its 52-Week Low?
Recently listed biotech stock Comera Life Sciences is trading near its 52-week low. The stock is down more than 75% year-to-date. Although the $15 million purchase agreement with Arena Business Solutions is expected to help it invest in its product pipeline and formulation platform SQore, will it be wise to…
StockNews.com ·
Benzinga
StockNews.com
